Volume 20, Number 1—January 2014
Dispatch
Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
Steffi Silling
, Ulrike Wieland, Marko Werner, Herbert Pfister, Anja Potthoff, and Alexander Kreuter
, Ulrike Wieland, Marko Werner, Herbert Pfister, Anja Potthoff, and Alexander Kreuter
Table
Flow cytometric immunophenotyping results before and after human papillomavirus vaccination in a patient with splenectomy*
| Cell type (reference range) | Results before vaccination† | Results after vaccination‡ |
|---|---|---|
| CD3 cell count | ||
| Absolute (690–2,540 cells/μL) | 2,729 cells/μL | 1,770 cells/μL |
| Relative (55%–84%) |
50% |
55% |
| CD4 cell count | ||
| Absolute (410–1,590 cells/μL) | 602 cells/μL | 457 cells/μL |
| Relative (31%–60%) |
11% |
14% |
| CD8 cell count | ||
| Absolute (190–1,140 cells/μL) | 2,149 cells/μL | 1,339 cells/μL |
| Relative (13%–41%) |
40% |
41% |
| CD4/CD8 ratio (0.8–2.0) | 0.28 | 0.34 |
*Boldface indicates results below or above the reference range. Vaccination was started on July 19, 2010, the second dose was given 2 months later in September 2010, and the third dose was given 4 months later in January 2011.
†February 2010.
‡March 2011.
Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.